Silver Book Fact

Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.

Bearse M, Adams A, Han Y, Schneck M, et al. A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy. Prog Retin Eye Res. 2006; 25(5): 425-448. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773701/

Reference

Title
A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy
Publication
Prog Retin Eye Res
Publication Date
2006
Authors
Bearse M, Adams A, Han Y, Schneck M, et al
Volume & Issue
Volume 25, Issue 5
Pages
425-448
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.  
  • Of the 8 million older Americans at high risk of developing advanced age-related macular degeneration (AMD), 1.3 million will develop advanced AMD within 5 years. However, the NEI-sponsored Age-Related Eye…  
  • It is estimated that proper treatment and monitoring of the eyes of diabetics could reduce new cases of diabetic retinopathy by 90%.  
  • Laser Treatment for DR
    Laser treatment of PDR can reduce the 5-year risk of blindness by 90%, and the risk of visual loss from DME by 50%.  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.